Inhibition of tyrosine degradation in vivo by the dopa decarboxylase blocking agent NSD-1034.

Experientia ·Vol. 24 ·No. 5 ·1968-05-15 ·Pages 429-30

Hempel K, Männl HF

Abstract

暂无摘要

MeSH Terms

Acetoacetates/metabolism Adrenal Glands/metabolism Aminobutyrates/metabolism Animals Aromatic Amino Acid Decarboxylase Inhibitors Aspartic Acid/metabolism Brain Stem/metabolism Cats Chickens Depression, Chemical Fumarates/metabolism Glutamates/metabolism Hydrazines/pharmacology Tritium Tyrosine/blood,metabolism

Chemicals

Acetoacetates Aminobutyrates Aromatic Amino Acid Decarboxylase Inhibitors Fumarates Glutamates Hydrazines Tritium Aspartic Acid Tyrosine

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Hempel K

Männl H F

References (9)

9 references, click to expand

Alternate pathways of phydroxyphenylacetic acid formation in the rat.
Biochim Biophys Acta. 1961 Feb 18;47:393-4 PMID: 13785403
MULTIPLE INHIBITORY EFFECTS OF ALPHA-METHYLAMINO ACIDS ON THE METABOLISM OF C14-LABELED TYROSINE, DOPA AND ALPHA-METHYLDOPA.
J Pharmacol Exp Ther. 1965 May;148:252-61 PMID: 14301016
Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues.
Biochem Biophys Res Commun. 1964;14:543-9 PMID: 5836553
[On the formation of H-3-dopa from H-3-tyrosine and determination of the dopa synthesis rate in the fowl and cat adrenal gland under in vivo conditions].
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;257(4):391-408 PMID: 4232726
TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.
J Biol Chem. 1964 Sep;239:2910-7 PMID: 14216443
The conversion of H3-tyrosine to H3-dopa in the adrenal glands under in vivo conditions.
Experientia. 1966 Oct 15;22(10):689-90 PMID: 5971927
EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
Int J Neuropharmacol. 1964 May;3:177-88 PMID: 14336525
Aromatic L-amino acid decarboxylase.
J Biol Chem. 1962 Jan;237:89-93 PMID: 14466899
Studies on dopa decarboxylase inhibitors in vivo by use of C14-carboxyl-labeled dopa.
Proc Soc Exp Biol Med. 1962 Dec;111:793-8 PMID: 13952652

Article Info

Journal

Experientia

Abbr.

Experientia

ISSN

0014-4754

DOI

10.1007/BF02144368

Published

1968-05-15

Pages

429-30

Language

English

Region

Switzerland

NLM ID

0376547

Subset

External Links

PubMed source DOI: 10.1007/BF02144368

Analysis Services

Inhibition of tyrosine degradation in vivo by the dopa decarboxylase blocking agent NSD-1034.

Contact

WeChat Official Account